Purpose of Review Diabetic retinopathy (DR) is one of the most common complications associated with chronic hyperglycemia seen in patients with diabetes mellitus. While many facets of DR are still not fully understood, animal studies have contributed significantly to understanding the etiology and progression of human DR. This review provides a comprehensive discussion of the induced and genetic DR models in different species and the advantages and disadvantages of each model. Recent Findings Rodents are the most commonly used models, though dogs develop the most similar morphological retinal lesions as those seen in humans, and pigs and zebrafish have similar vasculature and retinal structures to humans. Nonhuman primates can also develop ...
Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—inc...
Micro- and macro-vascular complications are the leading causes of morbidity and mortality in type 1 ...
Micro- and macro-vascular complications are the leading causes of morbidity and mortality in type 1 ...
Diabetic retinopathy (DR) is a microvascular complication associated with chronic exposure to hyperg...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and one of the m...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Diabetic retinopathy (DR) is one of the major complications of diabetes. Although great efforts have...
Ocular complications of diabetes in humans are reviewed briefly, and experimental models available f...
Ocular complications of diabetes in humans are reviewed briefly, and experimental models available f...
Diabetes is a group of metabolic diseases leading to dysfunction of various organs, including ocular...
Diabetes is a group of metabolic diseases leading to dysfunction of various organs, including ocular...
Purpose. Diabetic retinopathy (DR) is a major cause of blindness globally. Investigating the underly...
Abstract The paucity of animal models exhibiting full pathology of diabetic retinopathy (DR) has imp...
Diabetes mellitus is a lifelong, incapacitating metabolic disease associated with chronic macrovascu...
Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—inc...
Micro- and macro-vascular complications are the leading causes of morbidity and mortality in type 1 ...
Micro- and macro-vascular complications are the leading causes of morbidity and mortality in type 1 ...
Diabetic retinopathy (DR) is a microvascular complication associated with chronic exposure to hyperg...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and one of the m...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Diabetic retinopathy (DR) is one of the major complications of diabetes. Although great efforts have...
Ocular complications of diabetes in humans are reviewed briefly, and experimental models available f...
Ocular complications of diabetes in humans are reviewed briefly, and experimental models available f...
Diabetes is a group of metabolic diseases leading to dysfunction of various organs, including ocular...
Diabetes is a group of metabolic diseases leading to dysfunction of various organs, including ocular...
Purpose. Diabetic retinopathy (DR) is a major cause of blindness globally. Investigating the underly...
Abstract The paucity of animal models exhibiting full pathology of diabetic retinopathy (DR) has imp...
Diabetes mellitus is a lifelong, incapacitating metabolic disease associated with chronic macrovascu...
Vision loss in diabetic retinopathy (DR) is ascribed primarily to retinal vascular abnormalities—inc...
Micro- and macro-vascular complications are the leading causes of morbidity and mortality in type 1 ...
Micro- and macro-vascular complications are the leading causes of morbidity and mortality in type 1 ...